Prognostic impact of elevated fatty acid‐binding protein 1 in patients with heart failure

Prognostic impact of elevated fatty acid‐binding protein 1 in patients with heart failure

Abstract Aims Few biomarkers to evaluate pathophysiological changes in extra‐cardiac tissues have been identified in patients with heart failure (HF). Fatty acid‐binding protein 1 (FABP), also known as liver FABP, is predominantly expressed in the liver. Circulating FABP1 has been proposed to be a s...

Full description

Bibliographic Details
Main Authors: Kazuki Kagami, Hiroaki Sunaga, Hidemi Sorimachi, Tomonari Harada, Kuniko Yoshida, Toshimitsu Kato, Koji Kurosawa, Ryo Kawakami, Norimichi Koitabashi, Tatsuya Iso, Takeshi Adachi, Masahiko Kurabayashi, Masaru Obokata
Format: Article
Language:English
Published: Wiley 2021-04-01
Series:ESC Heart Failure
Subjects:
Heart failure
Fatty acid‐binding protein
Biomarkers
Cardio‐hepatic interaction
Online Access:https://doi.org/10.1002/ehf2.13239

Similar Items

Similar Items